山东医药2024,Vol.64Issue(29) :39-43.DOI:10.3969/j.issn.1002-266X.2024.29.009

自拟丹星止颤方对帕金森病小鼠运动障碍、神经元损伤的改善作用及其机制

Ameliorative effects of self-formulated Danxing Zhichan decoction on dyskinesia and neuronal damage in mice with Parkinson's disease and the mechanism

胡楠 闫咏梅 李涛 杨一帆 彭涛 刘泽华 徐培丽 谢欣纯
山东医药2024,Vol.64Issue(29) :39-43.DOI:10.3969/j.issn.1002-266X.2024.29.009

自拟丹星止颤方对帕金森病小鼠运动障碍、神经元损伤的改善作用及其机制

Ameliorative effects of self-formulated Danxing Zhichan decoction on dyskinesia and neuronal damage in mice with Parkinson's disease and the mechanism

胡楠 1闫咏梅 2李涛 1杨一帆 2彭涛 1刘泽华 3徐培丽 1谢欣纯1
扫码查看

作者信息

  • 1. 陕西中医药大学第一临床医学院,陕西咸阳 712000
  • 2. 陕西中医药大学第一临床医学院,陕西咸阳 712000;陕西中医药大学附属医院脑病一科
  • 3. 陕西省人民医院中医科
  • 折叠

摘要

目的 观察自拟丹星止颤方对帕金森病小鼠运动障碍、神经元损伤的改善作用并探讨其机制.方法 雄性C57BL/6小鼠48只,随机分为对照组、模型组、阳性对照组及丹星止颤方低、中、高剂量组,每组8只.除对照组外,各组均采用鱼藤酮溶液灌胃制备PD模型,对照组给予生理盐水灌胃,每天1次,连续28 d.造模成功后,丹星止颤方低、中、高剂量组给予丹星止颤方混悬液11.1、22.2、44.4 g/(kg·d)灌胃,阳性对照组给予美多芭混悬液112.5 mg/(kg·d)灌胃,对照组、模型组给予0.4 mL生理盐水灌胃,每天1次,连续28 d.采用网格实验及旋转杆实验观察小鼠运动能力,免疫组织化学法检测小鼠中脑黑质区α突触核蛋白(α-Syn),Western blotting法检测小鼠脑组织Toll样受体4(TLR4)、核因子κB(NF-κB)p65、α-Syn蛋白.结果 小鼠移动潜伏期对照组<阳性对照组、丹星止颤方中剂量组<丹星止颤方高剂量组<丹星止颤方低剂量组、模型组,旋转杆保持时间对照组>阳性对照组、丹星止颤方中剂量组>丹星止颤方高剂量组>丹星止颤方低剂量组、模型组(P均<0.05).小鼠中脑黑质区α-Syn阳性细胞比例对照组<阳性对照组、丹星止颤方中剂量组<丹星止颤方高剂量组<丹星止颤方低剂量组、模型组(P均<0.05).小鼠脑组织TLR4、NF-κB p65、α-Syn蛋白表达对照组<阳性对照组、丹星止颤方中剂量组<丹星止颤方高剂量组<丹星止颤方低剂量组、模型组(P均<0.05).结论 自拟丹星止颤方可改善PD小鼠运动障碍及神经元损伤,其机制可能与调控TLR4/NF-κB通路从而抑制中枢神经炎症有关.

Abstract

Objective To observe the ameliorative effects of the self-formulated Danxing Zhichan decoction on the dyskinesia and neuronal damage in mice with Parkinson's disease and to explore the mechanism.Methods Forty-eight male C57BL/6 mice were randomly divided into the control group,model group,positive control group,and low-,medi-um-and high-dose Danxing Zhichan decoction groups,with eight mice in each group.The PD models were prepared by ga-vage with rotenone solution in all groups except the control group,and mice in the control group were given saline by ga-vage once a day for 28 d.After successful modeling,mice in the low-,medium-and high-dose Danxing Zhichan decoction groups were given Danxing Zhichan decoction 11.1,22.2 and 44.4 g/(kg·d)by gavage,and mice in the positive control group were given Medoba Suspension 112.5 mg/(kg·d)by gavage,and mice in the control group and model group were given 0.4 mL normal saline by gavage once a day for 28 d.The motor ability of mice was observed using the grid test and the rotating rod test,and the α synaptic nuclear proteins(α-Syn)in the nigral region of the midbrain was detected by im-munohistochemistry,and the Toll-like receptor 4(TLR4),nuclear factor-κB(NF-κB)p65,and α-Syn protein were de-tected by Western blotting.Results Mouse movement latency was as follows:control group<positive control group,me-dium-dose Danxing Zhichan decoction group<high-dose Danxing Zhichan decoction group<low-dose Danxing Zhichan de-coction group and model group,and the rotating rod holding time was as follows:control group>positive control group,medium-dose Danxing Zhichan decoction group>high-dose Danxing Zhichan decoction group>low-dose Danxing Zhichan decoction group and model group(all P<0.05).The proportion of a-Syn positive cells in the substantia nigra region of mouse midbrain was as follows:control group<positive control group,medium-dose Danxing Zhichan decoction group<high-dose Danxing Zhichan decoction group<low-dose Danxing Zhichan decoction group and model group(all P<0.05),and the TLR4,NF-κB p65 and a-Syn protein expression were as follows:control group<positive control group,medium-dose Danxing Zhichan decoction group<high-dose Danxing Zhichan decoction group<low-dose Danxing Zhichan decoc-tion group and model group(all P<0.05).Conclusion Self-formulated Danxing Zhichan decoction can alleviate the dys-kinesia and neuronal damage in PD mice,and its mechanism may be related to the regulation of TLR4/NF-κB pathway and thus inhibiting the central neuroinflammation.

关键词

帕金森病/丹星止颤方/运动障碍/神经元损伤/Toll样受体4/核因子κB

Key words

Parkinson's disease/Danxing Zhichan decoction/dyskinesia/neuronal injury/Toll-like receptor 4/nuclear factor-κB

引用本文复制引用

基金项目

国家岐黄学者支持项目(国中医药人教函20226号)

陕西省科技厅陕西省重点研发计划重点产业创新链(群)社会发展领域研究课题项目(2021ZDLSF04-13)

陕西省中医脑病学重点实验项目(KF202316)

中西医结合临床协作创新项目(GYZ-KJS-2021-001)

陕西省教育厅重点实验室科研计划项目(19JS022)

陕西省重点研发计划项目(2020ZDLSF05-14)

研究生创新实践能力提升项目(CXSJ202325)

出版年

2024
山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
段落导航相关论文